Mazanti_Interiør_kbh 4_low.jpg (1)

Danish quantum computing startup Kvantify secures EUR 10 million in seed funding

Kvantify, a prominent quantum software start-up, has successfully closed a EUR 10 million seed round. The round was led by Dreamcraft Ventures together with biotech investor Lundbeckfonden BioCapital and the private investment company 2degrees. The round had further participation from Redstone QAI Quantum Fund, 2xN, and Danmarks Eksport- og Investeringsfond (EIFO). 

Mazanti Transactions advised the total group of investors in connection with the financing round.

Kvantify, founded in 2022 and based in Denmark, is a pioneering quantum software company building a quantum-ready drug discovery platform. The platform is designed to significantly accelerate the drug discovery process by improving the efficiency and accuracy, reducing the timeline for drug development, and address major causes of failure in drug discovery. 

The investment will accelerate the development of Kvantify’s innovative solutions that aim to address complex problems in drug discovery. It will enable Kvantify to strengthen its position as a global leader in quantum computing, with an initial focus on developing applications for the life science sector.

The seed round stands out not just for its substantial size, but also for the strategic alignment of the new investors with Kvantify’s mission.

Mazanti Transactions advised the investors on all aspects of the investment in Kvantify.

Read more in Børsen here (in Danish) and here.